Dept. of the Army -- USAMRAA logo

DoW Tuberous Sclerosis Complex, Clinical Translational Research Award

Dept. of the Army -- USAMRAA

Funding Amount

$3,500,000 total

Deadline

August 6, 2026

61 days left

Grant Type

federal

Overview

DoW Tuberous Sclerosis Complex, Clinical Translational Research Award

Summary: The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Translational Research Award (CTRA) supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis or treatment of tuberous sclerosis complex (TSC). Distinctive Features: This funding mechanism allows for multiple Principal Investigators (PIs). Only the initiating PI will submit a pre-application, but all PIs will need to submit full applications. The partnering PI(s) application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.

Details

  • Agency: Dept. of the Army -- USAMRAA
  • Department: Department of Defense
  • Opportunity #: HT942526TSCRPCTRA
  • Total Funding: $3,500,000
  • Expected Awards: 2
  • Instrument: grant

Eligibility

Eligible Applicant Types

unrestricted

Focus Areas & Funding Uses

Fields of Work

science-researchhealthcare

Categories

Browse similar grants by category

Related Grants

Similar grants from this funder and related organizations

Ready to apply for DoW Tuberous Sclerosis Complex, Clinical Translational Research Award?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

You found DoW Tuberous Sclerosis Complex, Clinical Translational Research Award. Now let's win it.

Start writing